Zobrazeno 11 - 20
of 33
pro vyhledávání: '"Jianghua Qiao"'
Autor:
Juntao Li, Yibing Chen, Huan Jin, Lina Wang, Jianghua Qiao, Qiming Wang, Yanjun Mi, Zhengzhi Zou, Zhenduo Lu
Publikováno v:
Biochemical and Biophysical Research Communications. 558:216-223
BET inhibitor (BETi) has potential therapeutic effects on human cancer especially in breast cancer. However, the detailed mechanisms remain unclear. Herein, we found that BETi JQ1 and I-BET-151 (I-BET) activated ATF2 through JNK1/2 pathway in breast
Autor:
Muhammad Sarim, Jian Xu, Peng Zhang, Maqsood Ur Rahman, Benazeer Iqbal, Jianghua Qiao, Fei Ke, Yazhou Ran
Publikováno v:
Palaeogeography, Palaeoclimatology, Palaeoecology. 610:111353
Autor:
Ping Chen, Zhenzhen Liu, Lina Wang, Jingyang Zhang, Dechuang Jiao, Zhenduo Lu, Jiujun Zhu, Jianghua Qiao, Xuhui Guo
Publikováno v:
Journal of Cellular and Molecular Medicine
Recent reports showed that haematological and neurological expressed 1‐like (HN1L) gene participated in tumorigenesis and tumour invasion. However, the expression and role of HN1L in breast cancer remain to be investigated. Here, bioinformatics, we
Autor:
Huan Jin, Qiming Wang, Zhengzhi Zou, Lina Wang, Jianghua Qiao, Yibing Chen, Ting Huang, Longlong Gong, Lingfeng Liu, Yanjun Mi
Publikováno v:
Biochemical and Biophysical Research Communications. 530:402-409
BET inhibitors (BETi) exert an excellent anti-cancer activity in breast cancer. However, the identification of new potential targets to enhance breast cancer sensitivity to BETi is still an enormous challenge. Both NR5A2 and NCOA3 are frequently invo
Autor:
Min Yan, Quchang Ouyang, Tao Sun, Limin Niu, Jin Yang, Li Li, Yuhua Song, Chunfang Hao, Zhanhong Chen, Armando Orlandi, Naohiro Ishii, Kazuaki Takabe, Gianluca Franceschini, Francesco Ricci, Claire Verschraegen, Zhenzhen Liu, Mengwei Zhang, Huimin Lv, Liping Liu, Xiaohong Yang, Huawu Xiao, Zhichao Gao, Xiaorui Li, Fangyuan Dong, Xiuchun Chen, Jianghua Qiao, Guifang Zhang
Publikováno v:
The Lancet. Oncology. 23(3)
Patients with HER2-positive metastatic breast cancer have a high risk of developing brain metastases. Efficacious treatment options are scarce. We investigated the activity and safety of pyrotinib plus capecitabine in patients with HER2-positive meta
Autor:
Zhenzhen Liu, Chengzheng Wang, Xiuchun Chen, Jiujun Zhu, Xianfu Sun, Qingxin Xia, Zhenduo Lu, Jianghua Qiao, Yong Zhou, Haixue Wang, Yi Wang, Min Yan
Publikováno v:
European journal of cancer (Oxford, England : 1990). 165
Panphila evaluated pyrotinib plus trastuzumab, docetaxel and carboplatin as neoadjuvant therapy for early breast cancer (BC), and investigated the predictive role of immune cell subpopulations.In this multicentre phase 2 study, patients with human ep
Autor:
Zhenzhen Liu, Lanwei Guo, Lina Wang, Xiaolin Bian, Jianghua Qiao, Zhenduo Lu, Juntao Li, Xiaoxia Guo
Publikováno v:
Gland Surg
Background Sentinel lymph node (SLN) biopsy (SLNB) is the standard procedure for axillary staging in clinically node-negative (cN0) breast cancer patients. However, the positive rate of SLNs among cN0 stage patients is 26-35%. The identification of a
Publikováno v:
Gland Surg
BACKGROUND: Sentinel lymph node biopsy (SLNB) is the standard procedure for axillary staging in clinically node-negative (cN0) breast cancer patients. The positive rate of SLNs in cN0 stage patients ranges from 20.5% to 25.5%, so identifying appropri
Publikováno v:
Cellular & Molecular Biology Letters, Vol 25, Iss 1, Pp 1-13 (2020)
Cellular & Molecular Biology Letters
Cellular & Molecular Biology Letters
Background Long intergenic non-protein coding RNA00665 (LINC00665) plays a crucial tumorigenic role in many cancers, such as gastric cancer and lung adenocarcinoma. However, its role and mechanism of action in the progression of breast cancer (BC) ar
Publikováno v:
Ann Transl Med
BACKGROUND: The progression of breast cancer (BC) is highly dependent on the tumor microenvironment. Inflammation, stromal cells, and the immune landscape have been identified as significant drivers of BC in multiple preclinical studies. Therefore, t